MIPLYFFA (arimoclomol citrate)
METABOLIC MODIFIER - NEIMANN PICK DISEASE TYPE C (NPC) · NIEMANN-PICK DISEASE TYPE C
ACER THERAPEUTI
Drug class
Metabolic Modifier - Neimann Pick Disease Type C (NPC)
The term "Metabolic Modifier - Neimann Pick Disease Type C (NPC)" is an administrative and compendial formulary classification rather than a single standardized pharmacologic drug class. Read more about Metabolic Modifier - Neimann Pick Disease Type C (NPC)
3 drugs in this class 3 manufacturers
Drugs in Metabolic Modifier - Neimann Pick Disease Type C (NPC)
AQNEURSA (levacetylleucine)
METABOLIC MODIFIER - NEIMANN PICK DISEASE TYPE C (NPC) · NIEMANN-PICK DISEASE TYPE C ·+1
INTRABIO INC.
MIPLYFFA (arimoclomol citrate)
METABOLIC MODIFIER - NEIMANN PICK DISEASE TYPE C (NPC) · NIEMANN-PICK DISEASE TYPE C
ACER/ZEVRA THER
Filter & compare in the drug finder →
Opens the drug finder with Metabolic Modifier - Neimann Pick Disease Type C (NPC) preselected. Add indication or manufacturer filters there.
The term "Metabolic Modifier - Neimann Pick Disease Type C (NPC)" is an administrative and compendial formulary classification rather than a single standardized pharmacologic drug class.
It categorizes disease-specific therapies—such as heat shock protein amplifiers like arimoclomol and modified amino acids like levacetylleucine—indicated to manage neurological manifestations of Niemann-Pick disease type C, an inherited lysosomal storage disorder marked by impaired intracellular lipid trafficking.
Because individual agents within this heading possess distinct biochemical mechanisms, including chaperone-mediated lysosomal function enhancement and cellular metabolism normalization, the grouping functions primarily as a health-plan and therapeutic category rather than a uniform mechanistic class.
-
formularynavigator.com
The term "Metabolic Modifier - Neimann Pick Disease Type C (NPC)" is an administrative and compendial formulary classification rather than a single standardized pharmacologic drug class
-
formularynavigator.com
The term "Metabolic Modifier - Neimann Pick Disease Type C (NPC)" is an administrative and compendial formulary classification rather than a single standardized pharmacologic drug class It categorizes disease-specific therapies—such as heat shock protein amplifiers like arimoclomol and modified amino acids like levacetylleucine—indicated to manage neurological manifestations of Niemann-Pick disease type C, an inherited lysosomal storage disorder marked by impaired intracellular lipid trafficking...
-
connectrx.com
It categorizes disease-specific therapies—such as heat shock protein amplifiers like arimoclomol and modified amino acids like levacetylleucine—indicated to manage neurological manifestations of Niemann-Pick disease type C, an inherited lysosomal storage disorder marked by impaired intracellular lipid trafficking Because individual agents within this heading possess distinct biochemical mechanisms, including chaperone-mediated lysosomal function enhancement and cellular metabolism normalization,...
-
lablue.com
It categorizes disease-specific therapies—such as heat shock protein amplifiers like arimoclomol and modified amino acids like levacetylleucine—indicated to manage neurological manifestations of Niemann-Pick disease type C, an inherited lysosomal storage disorder marked by impaired intracellular lipid trafficking Because individual agents within this heading possess distinct biochemical mechanisms, including chaperone-mediated lysosomal function enhancement and cellular metabolism normalization,...
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.